Audited Results of Pfizer Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	2,281.35	2,193.17	2,424.76	2,610.99	2,238.55
Manufacturing Expenses	3.48	3.98	6.51	5.67	5.79
Personnel Expenses	371.33	347.80	331.68	403.67	361.06
Selling Expenses	56.75	85.59	61.59	74.38	65.02
Administrative Expenses	296.50	325.27	340.47	342.16	294.77
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,541.12	1,557.87	1,615.90	1,775.26	1,526.43
Operating Profit	740.23	635.30	808.86	835.73	712.12
Other Recurring Income	172.25	180.51	101.05	62.65	81.12
Adjusted PBDIT	912.48	815.81	909.91	898.38	793.24
Financial Expenses	8.41	15.41	13.39	10.49	15.11
Depreciation	60.79	62.28	105.51	115	109.41
Other Write offs	0	0	0	0	0
Adjusted PBT	843.28	738.12	791.01	772.89	668.72
Tax Charges	248.49	194.74	200.08	160.33	171.11
Adjusted PAT	594.79	543.38	590.93	612.56	497.61
Non Recurring Items	172.81	7.95	33	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	767.60	551.33	623.93	612.56	497.61
Equity Dividend	160.13	182.99	297.35	160.12	1,509.66
Preference Dividend	0	0	0	0	0
Retained Earnings	2,435.86	1,828.39	1,460.05	1,133.47	681.03

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article